---
title: "$100 Invested In Q32 Bio 5 Years Ago Would Be Worth This Much Today"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292676180.md"
description: "Q32 Bio (NASDAQ: QTTB) has outperformed the market over the past five years with an annualized return of 23.91%. A $100 investment made five years ago would now be worth $287.54, based on a current stock price of $18.72. The company currently holds a market capitalization of $317.42 million."
datetime: "2026-07-14T20:32:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292676180.md)
  - [en](https://longbridge.com/en/news/292676180.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292676180.md)
generator: "portal-rs"
---

# $100 Invested In Q32 Bio 5 Years Ago Would Be Worth This Much Today

Q32 Bio (NASDAQ:QTTB) has outperformed the market over the past 5 years by 11.82% on an annualized basis producing an average annual return of 23.91%. Currently, Q32 Bio has a market capitalization of $317.42 million.

**Buying $100 In QTTB:** If an investor had bought $100 of QTTB stock 5 years ago, it would be worth **$287.54** today based on a price of $18.72 for QTTB at the time of writing.

### Q32 Bio’s Performance Over Last 5 Years

![comp_fig](https://imageproxy.pbkrs.com/https://cdn.benzinga.com/files/images/story/2026/07/14/bfc7cecf6ee7ffd401201cf2ce14554b.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

*This article was generated by Benzinga's automated content engine and reviewed by an editor.*

### Related Stocks

- [QTTB.US](https://longbridge.com/en/quote/QTTB.US.md)

## Related News & Research

- [Q32 Bio Launches Flexible $14.2 Million ATM Program](https://longbridge.com/en/news/280852868.md)
- [Q32 Bio Inc. (NASDAQ:QTTB) Sees Large Increase in Short Interest](https://longbridge.com/en/news/293861610.md)
- [QTTB: Bempikibart showed strong efficacy and safety in severe alopecia areata, supporting registrational plans](https://longbridge.com/en/news/292490088.md)
- [Q32 Bio Reports Positive Phase 2a Alopecia Areata Results](https://longbridge.com/en/news/292517393.md)
- [Q32 Bio reports positive 36-week Phase 2a data for bempikibart in alopecia areata](https://longbridge.com/en/news/292477065.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**